Caricamento...
Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept
BACKGROUND: Alefacept treatment is highly effective in a select group patients with moderate-to-severe psoriasis, and is an ideal candidate to develop systems to predict who will respond to therapy. A clinical trial of 22 patients with moderate to severe psoriasis treated with alefacept was conducte...
Salvato in:
Autori principali: | , , , , |
---|---|
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
BioMed Central
2010
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2831811/ https://ncbi.nlm.nih.gov/pubmed/20152045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-5945-10-1 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|